Kane Biotech, Inc. (KNE.V)
0.025
0.00 (0.00%)
CAD |
TSXV |
Aug 25, 16:00
Kane Biotech Shareholders Equity (Quarterly) : -1.418M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -1.418M |
| September 30, 2025 | -0.7934M |
| June 30, 2025 | -0.235M |
| March 31, 2025 | -1.134M |
| December 31, 2024 | -1.629M |
| September 30, 2024 | -0.6886M |
| June 30, 2024 | -0.7217M |
| March 31, 2024 | -11.73M |
| December 31, 2023 | |
| September 30, 2023 | -9.192M |
| June 30, 2023 | -8.491M |
| March 31, 2023 | -7.759M |
| December 31, 2022 | -6.523M |
| September 30, 2022 | -5.682M |
| June 30, 2022 | -4.718M |
| March 31, 2022 | -4.878M |
| December 31, 2021 | -3.886M |
| September 30, 2021 | -2.760M |
| June 30, 2021 | -2.066M |
| March 31, 2021 | -2.151M |
| December 31, 2020 | -1.490M |
| September 30, 2020 | -0.7198M |
| June 30, 2020 | 0.1509M |
| March 31, 2020 | 0.5902M |
| December 31, 2019 | 0.8368M |
| Date | Value |
|---|---|
| September 30, 2019 | -0.486M |
| June 30, 2019 | 0.0452M |
| March 31, 2019 | -1.630M |
| December 31, 2018 | -0.9848M |
| September 30, 2018 | 0.2661M |
| June 30, 2018 | 1.199M |
| March 31, 2018 | 1.891M |
| December 31, 2017 | 2.738M |
| September 30, 2017 | 3.594M |
| June 30, 2017 | 0.4424M |
| March 31, 2017 | 1.117M |
| December 31, 2016 | 1.318M |
| September 30, 2016 | 1.944M |
| June 30, 2016 | 2.553M |
| March 31, 2016 | 0.2516M |
| December 31, 2015 | 0.4503M |
| September 30, 2015 | 0.5058M |
| June 30, 2015 | 0.6055M |
| March 31, 2015 | 0.9263M |
| December 31, 2014 | 1.299M |
| September 30, 2014 | 0.5421M |
| June 30, 2014 | 0.872M |
| March 31, 2014 | 1.358M |
| December 31, 2013 | 1.283M |
| September 30, 2013 | 1.331M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Quest PharmaTech, Inc. | 26.43M |
| BriaCell Therapeutics Corp. | 32.75M |
| Vaxil Bio Ltd. | 1.258M |
| Waverley Pharma, Inc. | -2.725M |
| Goldcoast Resource Corp. | 0.6796M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.811M |
| Total Liabilities (Quarterly) | 3.229M |
| Debt to Equity Ratio | -1.352 |
| Current Ratio | 0.4535 |
| Net Debt Paydown Yield | 1.34% |